PCM
OCUL icon

Peregrine Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Peregrine Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$8M Buy
861,962
+14,494
+2% +$135K 0.24% 114
2025
Q1 		$6.21M Buy
+847,468
New +$6.21M 0.21% 145